These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease. Price DL, Cork LC, Struble RG, Whitehouse PJ, Kitt CA, Walker LC. Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283 [No Abstract] [Full Text] [Related]
7. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis. Förstl H, Levy R, Burns A, Luthert P, Cairns N. Pharmacopsychiatry; 1994 Jan; 27(1):11-5. PubMed ID: 8159776 [Abstract] [Full Text] [Related]
8. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Bird TD, Stranahan S, Sumi SM, Raskind M. Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276 [Abstract] [Full Text] [Related]
9. Manipulation of the cholinergic system. Geroldi C, Bianchetti A, Trabucchi M. Funct Neurol; 1997 Sep; 12(3-4):187-91. PubMed ID: 9218975 [No Abstract] [Full Text] [Related]
10. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B. Neuroscience; 2004 Sep; 125(3):769-76. PubMed ID: 15099690 [Abstract] [Full Text] [Related]
11. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. Prog Brain Res; 1986 Sep; 70():105-32. PubMed ID: 3554348 [No Abstract] [Full Text] [Related]
12. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK. Brain Res; 1983 Dec 19; 289(1-2):375-9. PubMed ID: 6362777 [Abstract] [Full Text] [Related]
13. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Teipel SJ, Flatz WH, Heinsen H, Bokde AL, Schoenberg SO, Stöckel S, Dietrich O, Reiser MF, Möller HJ, Hampel H. Brain; 2005 Nov 19; 128(Pt 11):2626-44. PubMed ID: 16014654 [Abstract] [Full Text] [Related]
14. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease. Pearson RC, Powell TP. J Neural Transm Suppl; 1987 Nov 19; 24():139-46. PubMed ID: 3119773 [Abstract] [Full Text] [Related]
15. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view]. Brion S, Plas J, Massé G. Encephale; 1986 Nov 19; 12(3):111-4. PubMed ID: 3769856 [Abstract] [Full Text] [Related]
16. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NP, Quirion R. Neuroscience; 1986 Dec 19; 19(4):1279-91. PubMed ID: 3822122 [Abstract] [Full Text] [Related]
18. Cholinergic neuropathology in a mouse model of Alzheimer's disease. German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL. J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807 [Abstract] [Full Text] [Related]
19. Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei. Steriade M, Parent A, Paré D, Smith Y. Brain Res; 1987 Apr 07; 408(1-2):372-6. PubMed ID: 2439172 [Abstract] [Full Text] [Related]
20. [Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease ]. Coralli MV, Zanotti E, Salsi A. Recenti Prog Med; 1986 Sep 07; 77(9):436-9. PubMed ID: 3541087 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]